FFA
EWTX icon

Farther Finance Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Farther Finance Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Sell
558
-87
-13% -$3K ﹤0.01% 3883
2026
Q1 		$21.4K Sell
645
-14
-2% -$404 ﹤0.01% 3613
2025
Q4 		$16.4K Buy
659
+101
+18% +$2.03K ﹤0.01% 3572
2025
Q3 		$9.05K Buy
558
+184
+49% +$2.61K ﹤0.01% 3484
2025
Q2 		$4.9K Buy
374
+366
+4,575% +$5.28K ﹤0.01% 3366
2025
Q1 		$161 Hold
8
– – ﹤0.01% 3989
2024
Q4 		$214 Hold
8
– – ﹤0.01% 3646
2024
Q3 		$214 Sell
8
-12
-60% -$239 ﹤0.01% 3635
2024
Q2 		$388 Buy
20
+12
+150% +$209 ﹤0.01% 3332
2024
Q1 		$144 Hold
8
– – ﹤0.01% 3325
2023
Q4 		$88 Buy
+8
New +$56 ﹤0.01% 3319

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Farther Finance Advisors's EWTX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Edgewise Therapeutics (EWTX) stake by 13% in Q2 2026, selling an estimated $3K and leaving 558 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

Farther Finance Advisors first reported a position in EWTX in Q4 2023 and has held it in 11 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Farther Finance Advisors held 558 shares of Edgewise Therapeutics worth $22.7K as of Q2 2026.
  • Farther Finance Advisors sold 87 Edgewise Therapeutics shares in Q2 2026, an estimated $3K.
  • Edgewise Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3883 holding.
  • Farther Finance Advisors first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.